Company / SG&A per Share
Inhibrx Biosciences, Inc. SG&A per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.61
FY2025
5-year range
$0.62 / $2.49
FY2023-FY2025
Trend
+159.5%
vs FY2024
Sector context
#91 of 210
Health Care
What the data says
At $1.61, Inhibrx Biosciences, Inc.'s sg&a per share ranks #120 of 210 in the Health Care sector. Improved from $2.49 to $1.61 over the past 2 years.
Based on SEC 10-K filings.
1.61 in FY2025.
Improved from $2.49 to $1.61 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#120 of 210 in Health CareTop 57% of 210This company $1.61 Sector average $40.75
▼
-96.1% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 159.5% year-over-year.
- Ranks #91 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.61 | +159.5% |
| FY2024 | $0.62 | -75.1% |
| FY2023 | $2.49 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026